P935: EARLY RELAPSE WITHIN 18 MONTHS (ER18) IS A POWERFUL DYNAMIC PREDICTOR FOR PROGNOSIS AND COULD REVISE STATIC RISK DISTRIBUTION IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA

• Wenqiang Yan,
• Jian Cui,
• Jingyu Xu,
• Huishou Fan,
• Yan Xu,
• Lugui Qiu,
• Gang An

Affiliations

Wenqiang Yan

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Jian Cui

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Jingyu Xu

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Huishou Fan

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Yan Xu

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Lugui Qiu

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China

Gang An

1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Department of lymphoma, Tianjin, China